Integra Therapeutics closes a €10.7 million funding round, with participation from Columbus, EIC Fund, CDTI, Invivo, Takeda, and AdBio

by CDTI Innovación

The funds will be used to incorporate new advances into the FiCAT gene writing platform, validate various next generation CAR-T therapies in the preclinical phase and expand the FiCAT cell engineering...

Read more

Criteria Bio Ventures participates in NRG Therapeutics’ £50m Series B round

by CriteriaCaixa

The financing was led by SV Health Investors’ Dementia Discovery Fund, joined by a syndicate of leading international life science venture investors: British Business Bank, M Ventures, Novartis Vent...

Read more

Asabys Partners Leads €10 Million Extension of SafeHeal’s Oversubscribed Series C Financing to Accelerate Commercialization of Colovac®

by Asabys Partners

Asabys joins SafeHeal’s global investor syndicate, which includes Sofinnova, Solar Eclipse and a Leading Multinational Life Sciences Corporation, bringing additional resources and strategic expertis...

Read more

Gyala Therapeutics raises €3 million from Invivo Partners, Nara Capital, and CDTI Innvierte

by CDTI Innovación

Gyala Therapeutics is a biotechnology company focused on developing next-generation immunotherapies to treat hematological cancers with unmet medical needs. Its lead program is GYA01, a first-in-class...

Read more

Buenavista leads a €15 million funding round in Highlight Therapeutics

by Buenavista Equity Partners

Buenavista Equity Partners, through its specialized fund BV Healthcare Growth Innvierte I (BHG I) created in collaboration with Columbus Venture Partners, has announced its entry into the shareholding...

Read more

VarmX, an Ysios portfolio company, partners with CSL in a strategic collaboration and option agreement to develop novel investigational coagulation treatment

by Ysios Capital

Under the terms of the strategic collaboration agreement, CSL will fully fund VarmX’s global Phase 3 EquilibriX-S trial evaluating VMX-C001 in patients taking FXa DOACs who require urgent surgery. C...

Read more

Columbus Venture Partners launches the Columbus Life Sciences Fund V with a target of €200 million

by Columbus Venture Partners

Columbus Life Sciences Fund V will primarily invest in European and U.S.-based technology companies in the fields of biotechnology, advanced therapies, medical devices, precision medicine, diagnostics...

Read more

ARTHEx Biotech Upsizes Series B Financing Round to $87 millones

by Columbus Venture Partners

The Series B extension financing was led by Bpifrance and joined by all existing shareholders, including AdBio Partners, CDTI Innovación, Columbus Venture Partners, European Innovation Council (EIC),...

Read more

Unirisco and Xesgalicia invest in Batea Oncology

by Xesgalicia

The company focuses on researching and developing new technologies for the treatment of oncological diseases, with a particular focus on Glioblastoma, an aggressive brain tumor in urgent need of new t...

Read more

CDTI Innovación invests in KOA Biotech alongside Swanlaab

by CDTI Innovación

Founded in 2021 as a spin-off of Pompeu Fabra University, KOA Biotech was born with the mission of revolutionizing aquaculture through cutting-edge technology. The company is transforming health manag...

Read more

Invivo Partners Launches €100M InvivoAI Fund to Accelerate Deeptech and AI Innovation in Spain

by Invivo Capital

Invivo Ventures AI will target early-stage companies applying AI to advance biotechnology and other science-driven domains. The fund is designed to capitalize on the surging momentum in AI, with deal ...

Read more

CDTI invests in Integra Therapeutics, together with Invivo, Columbus, and AdBio Partners

by CDTI Innovación

Innvierte SICC of CDTI Innovación invests in Integra Therapeutics, together with three co-investors, to develop a gene-editing platform for the treatment of oncological, autoimmune, and genetic disea...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Alantra Private Equity strengthens AIVOR...

by Alantra

AIVORIQ has grown significantly since Alantra PE launched the project....

Photos Stream